← back to search

Payal Kohli

Merck & Co., Inc., Rahway, NJ, USA (United States) · US
Area of research
Cardiology and Cardiovascular Medicine · Surgery
Research interest
Research interests include Atrial Fibrillation Management and Outcomes, Lipoproteins and Cardiovascular Health, Venous Thromboembolism Diagnosis and Management, and Antiplatelet Therapy and Cardiovascular Diseases.
h-index
22
citations
2,694
works
253
NIH funding
primary concept
email

Recent publications

PREVENT Equations: A New Era in Cardiovascular Disease Risk Assessment
Circulation Cardiovascular Quality and Outcomes 2024cited by 22position: middledoi
AMG145, a Monoclonal Antibody Against Proprotein Convertase Subtilisin Kexin Type 9, Significantly Reduces Lipoprotein(a) in Hypercholesterolemic Patients Receiving Statin Therapy
Circulation 2013cited by 175position: middledoi
A Clinician's Guide to the <scp>ABCs</scp> of Cardiovascular Disease Prevention: The Johns Hopkins Ciccarone Center for the Prevention of Heart Disease and American College of Cardiology Cardiosource Approach to the Million Hearts Initiative
Clinical Cardiology 2013cited by 65position: middledoi
NSAID Use and Association with Cardiovascular Outcomes in Outpatients with Stable Atherothrombotic Disease
The American Journal of Medicine 2013cited by 60position: firstdoi
AMG 145, a Monoclonal Antibody Against PCSK9, Facilitates Achievement of National Cholesterol Education Program–Adult Treatment Panel III Low-Density Lipoprotein Cholesterol Goals Among High-Risk Patients
Journal of the American College of Cardiology 2013cited by 51position: middledoi
Efficacy, safety, and tolerability of a monoclonal antibody to proprotein convertase subtilisin/kexin type 9 in combination with a statin in patients with hypercholesterolaemia (LAPLACE-TIMI 57): a randomised, placebo-controlled, dose-ranging, phase 2 study
The Lancet 2012cited by 423position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Elaine Hoffman · Takeda (United States)4 papers (2012–2013)Robert P. Giugliano · Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo3 papers (2012–2013)Nihar R. Desai · Yale New Haven Hospital3 papers (2012–2013)Robert C. Scott · Japan Real Estate Institute3 papers (2012–2013)Scott M. Wasserman · Amgen (United States)3 papers (2012–2013)Marc S. Sabatine · Smart Material (Germany)3 papers (2012–2013)Roger S. Blumenthal · Yale University2 papers (2013–2024)Jing Zhou · Qingdao University2 papers (2013–2013)Fannie Huang · University of Alabama at Birmingham2 papers (2012–2013)Seth S. Martin · Yale University2 papers (2013–2024)Ransi Somaratne · University of Alabama at Birmingham2 papers (2013–2013)William J. Rogers · Universidad Nacional del Centro de la Provincia de Buenos Aires2 papers (2012–2013)Steven Hsu · Johns Hopkins University1 papers (2013–2013) · 1 papers (2012–2012)Kim A. Eagle · Twitter (United States)1 papers (2013–2013) · 1 papers (2013–2013) · 1 papers (2012–2012)Tamar S. Polonsky · Atrium Health Wake Forest Baptist1 papers (2024–2024)Sidney C. Smith · Northwestern University1 papers (2013–2013)Darren K. McGuire · Saint Luke's Health System1 papers (2024–2024)